ha14-1 has been researched along with Leukemia L 1210 in 1 studies
ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate: a BH3 mimetic; synergistic induction of apoptosis by simultaneous disruption of the Bcl-2 and MEK/MAPK pathways in acute myelogenous leukemia
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kessel, D | 1 |
1 other study available for ha14-1 and Leukemia L 1210
| Article | Year |
|---|---|
Protection of Bcl-2 by salubrinal.
Topics: Animals; Apoptosis; Benzopyrans; Cinnamates; Eukaryotic Initiation Factor-2; Humans; Leukemia L1210; | 2006 |